DEB vs Thin-DES in DES-ISR: Long Term Outcomes (DEB Dragon Registry)

NCT04415216 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1369

Last updated 2021-09-21

No results posted yet for this study

Summary

Data regarding the usefulness of percutaneous coronary intervention (PCI) with drug eluting balloon (DEB) vs. thin struts drug eluting stents (thin-DES) for treating in-stent restenosis (ISR) in every day clinical practice is scarce. We aimed to evaluate comparing the efficacy and safety profile of DEB and thin-DES in DES-ISR.

Conditions

  • In Stent Restenosis

Interventions

DEVICE

percutaneous coronary intervention

Percutaneous coronary intervention with drug eluting balloon (DEB) vs. thin struts drug eluting stents (thin-DES) for treating in-stent restenosis (ISR)

Sponsors & Collaborators

  • Wojciech Wojakowski

    collaborator UNKNOWN
  • Medical University of Silesia

    lead OTHER

Eligibility

Sex
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-10
Primary Completion
2019-12-30
Completion
2020-03-01

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04415216 on ClinicalTrials.gov